The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period.
about
Diagnosis and management of hyponatremia in cancer patientsVasopressin Receptor Antagonists for the Correction of Hyponatremia in Chronic Heart Failure: An Underutilized Therapeutic Option in Current Clinical Practice?Role of tolvaptan in the management of hyponatremia in patients with lung and other cancers: current data and future perspectivesDoes Accidental Overcorrection of Symptomatic Hyponatremia in Chronic Heart Failure Require Specific Therapeutic Adjustments for Preventing Central Pontine Myelinolysis?Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapyParaneoplastic syndromes associated with lung cancerA rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptanHyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis.Hyponatremia secondary to the syndrome of inappropriate secretion of antidiuretic hormone (SIADH): therapeutic decision-making in real-life cases.Prevalence of Hyponatremia in Palliative Care Patients.Prognostic significance of serum LDH in small cell lung cancer: A systematic review with meta-analysis.SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptanResistance to BH3 mimetic S1 in SCLC cells that up-regulate and phosphorylate Bcl-2 through ERK1/2.Progress in the management of limited-stage small cell lung cancer.Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: A case reportRetrospective review of extra-pulmonary small cell carcinoma and prognostic factors.Serum Natrium Determines Outcome of Treatment of Advanced GIST with Imatinib: A Retrospective Study of 80 Patients from a Single InstitutionVasopressin receptor antagonists in patients with chronic heart failure.Hyponatremia as an independent prognostic factor in patients with terminal cancer.Clinical features and prognostic factors of small cell lung cancer: A retrospective study in 148 patients.Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients.Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study.Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trialsSmall Cell Lung Cancer Patient with Profound Hyponatremia and Acute Neurological Symptoms: An Effective Treatment with Fludrocortisone.Copeptin as a marker for arginine-vasopressin/antidiuretic hormone secretion in the diagnosis of paraneoplastic syndrome of inappropriate ADH secretion.Preoperative serum sodium is associated with cancer-specific survival in patients with upper urinary tract urothelial carcinoma treated by nephroureterectomy.Managing hyponatremia in lung cancer: latest evidence and clinical implications.Successful treatment by tolvaptan of the syndrome of inappropriate antidiuretic hormone secretion that may be associated with chemotherapy-induced tumour lysis in a patient with small-cell lung carcinoma.
P2860
Q27027817-3EE3E850-6F00-4626-A099-DED8C817B684Q28071921-FFB170B6-498C-4AA2-89E9-968000F6E71CQ28072768-D63CE667-FF42-45C6-9D1E-52025CE2551BQ30235394-7EC207BA-5286-4428-9632-439D40E6E044Q33618900-620613F7-F644-49A1-B3AA-BF9F665873D0Q34023610-912B87C0-4931-4937-BEF9-407E9122E9DDQ34976276-C2C9D090-46CC-4056-8EC9-931A3DCB7F12Q35612367-5BFD7FDB-B4C7-4145-8775-CAEE12008969Q35626444-418C1C01-63F7-418B-9FDC-EC7982765631Q35951966-893B95A0-F377-49E3-9FA6-33C824635A28Q35984979-CDECBF08-8032-4706-9E02-25446133DF8AQ36345973-7F4C4296-37F0-4D50-87AE-E81318BBAD92Q37046792-35EE6DBC-E0C8-44AF-A52F-DC733B667361Q37626969-0A96E2CF-CE3C-438E-A063-A8AD3DBDF088Q37652361-DBAF46FE-9E60-4326-8768-A9AC0A5DB0D6Q38152286-56AAA0A8-DA7A-498D-BD3A-5257903E7DDAQ38744540-D9408992-EC86-41BB-8036-49057F8869B6Q38954498-49E17165-472D-43DB-891C-4440C06D58B6Q39092737-96ABA452-34F4-48FA-883F-4E6A9B855137Q40438318-489AE5A0-9B46-491B-A13B-62884408FF4DQ41295884-C50BD3FB-0BF1-41D8-96F4-04BCEB9D6FBFQ42244095-53B05AF0-BE91-4E27-B255-372CEAB17C70Q42292313-3A6F4BBB-11AC-495C-AC9A-638F2AF13271Q42380825-77C28DAE-5BE1-4C8C-AC74-CD416F795368Q42435453-4C00DC25-8C32-4FC8-B1D0-3B34BC4B2A89Q43921926-7710C2C7-DE46-4272-B191-678BAAEB9A92Q48514630-E6C6E195-0559-4D75-91ED-4D09A33C6687Q54987051-161ABE68-CC6E-420A-8577-573907595FFA
P2860
The occurrence of hyponatremia in SCLC and the influence on prognosis: a retrospective study of 453 patients treated in a single institution in a 10-year period.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
The occurrence of hyponatremia ...... stitution in a 10-year period.
@en
The occurrence of hyponatremia ...... stitution in a 10-year period.
@nl
type
label
The occurrence of hyponatremia ...... stitution in a 10-year period.
@en
The occurrence of hyponatremia ...... stitution in a 10-year period.
@nl
prefLabel
The occurrence of hyponatremia ...... stitution in a 10-year period.
@en
The occurrence of hyponatremia ...... stitution in a 10-year period.
@nl
P2093
P1433
P1476
The occurrence of hyponatremia ...... stitution in a 10-year period.
@en
P2093
Karin Holmskov Hansen
Olfred Hansen
Peter Sørensen
P304
P356
10.1016/J.LUNGCAN.2009.05.015
P577
2009-06-16T00:00:00Z